The potency of ICLL’s novel adjuvant IC31® will be evaluated in the field of malaria Vienna and Seattle, January 16, 2008—Intercell AG (VSE, "ICLL") and the PATH Malaria Vaccine Initiative ...
Discover historical prices for ICLL.VI stock on Yahoo Finance. View daily, weekly or monthly format back to when stock was issued.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results